Peter Boumenot - Signify Health Chief Product Officer
| SGFYDelisted Stock | USD 30.49 0.00 0.00% |
Insider
Peter Boumenot is Chief Product Officer of Signify Health since 2020.
| Age | 41 |
| Tenure | 4 years |
| Phone | 855 984 5121 |
| Web | https://www.signifyhealth.com |
Signify Health Management Efficiency
The company has return on total asset (ROA) of 0.0254 % which means that it generated a profit of $0.0254 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1127) %, meaning that it created substantial loss on money invested by shareholders. Signify Health's management efficiency ratios could be used to measure how well Signify Health manages its routine affairs as well as how well it operates its assets and liabilities.Signify Health currently holds 333.1 M in liabilities with Debt to Equity (D/E) ratio of 0.35, which is about average as compared to similar companies. Signify Health has a current ratio of 5.13, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Signify Health's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Jessica Somers | Evolent Health | N/A | |
| Jon Maack | Definitive Healthcare Corp | N/A | |
| Jon Boumstein | National Research Corp | N/A | |
| Matthew Morris | Privia Health Group | 60 | |
| Jaap Mandema | Certara | N/A | |
| Daniel Burton | Health Catalyst | 49 | |
| Scott Perricelli | Phreesia | 47 | |
| Justin Steinman | Definitive Healthcare Corp | N/A | |
| Kate Jensen | Definitive Healthcare Corp | 38 | |
| Joseph Mirisola | Definitive Healthcare Corp | 40 | |
| Gillian Munson | Phreesia | 50 | |
| Michael Davidoff | Phreesia | 51 | |
| Peter Grua | Evolent Health | 66 | |
| Patrick Nelli | Health Catalyst | N/A | |
| Jona Raasch | National Research Corp | 65 | |
| Allison Hoffman | Phreesia | 53 | |
| MAAA FSA | Evolent Health | 51 | |
| Nicolette Sherman | Certara | 54 | |
| Ramin Sayar | Phreesia | 47 | |
| Craig Barbarosh | Evolent Health | 52 | |
| Dave Ross | Health Catalyst | N/A | |
Management Performance
| Return On Equity | -0.11 | |||
| Return On Asset | 0.0254 |
Signify Health Leadership Team
Elected by the shareholders, the Signify Health's board of directors comprises two types of representatives: Signify Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Signify. The board's role is to monitor Signify Health's management team and ensure that shareholders' interests are well served. Signify Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Signify Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Steven Senneff, President, Chief Financial Officer, Chief Administrative Officer | ||
| Stephen Wiggins, Director | ||
| Brandon Hull, Independent Director | ||
| Josh Builder, Chief Technology Officer | ||
| Jason Plagman, VP Relations | ||
| Erin Kelly, Chief Compliance Officer | ||
| Matthew Holt, Independent Chairman of the Board | ||
| Bradford Armbrester, CEO Director | ||
| Marc Rothman, Chief Medical Officer | ||
| Sam Pettijohn, Chief Growth Officer | ||
| Peter Boumenot, Chief Product Officer | ||
| Albert Notini, Independent Director | ||
| Kevin McNamara, Director | ||
| Laurence Orton, Chief Officer | ||
| Kyle Peterson, Independent Director | ||
| Taj Clayton, Independent Director | ||
| Vivian Riefberg, Independent Director | ||
| Susan Yun, Chief Officer | ||
| Adam McAnaney, General Counsel, Secretary | ||
| Laurel Douty, Executive Vice President - Clinical Operations, Episodes of Care Services | ||
| David Pierre, Chief Operating Officer | ||
| Lynn Shepherd, VP Communications | ||
| Kyle Armbrester, Chief Executive Officer, Director |
Signify Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Signify Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.11 | |||
| Return On Asset | 0.0254 | |||
| Profit Margin | (0.72) % | |||
| Operating Margin | 0.1 % | |||
| Current Valuation | 6.66 B | |||
| Shares Outstanding | 179.05 M | |||
| Shares Owned By Insiders | 0.97 % | |||
| Shares Owned By Institutions | 96.18 % | |||
| Number Of Shares Shorted | 15.71 M | |||
| Price To Earning | 127.17 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Signify Stock
If you are still planning to invest in Signify Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Signify Health's history and understand the potential risks before investing.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |